Nien Hsing Textile Co., Ltd. logo

Nien Hsing Textile Co., Ltd. (1451)

Market Closed
15 Jun, 05:30
TWSE TWSE
NT$
16. 90
+0.2
+1.1976%
NT$
3.43B Market Cap
25.26 P/E Ratio
4% Div Yield
139,327 Volume
0 Eps
NT$ 16.7
Previous Close
Add Transaction
Day Range
16.75 16.9
Year Range
16.3 19.25
Want to track 1451 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

1451 closed today higher at NT$16.9, an increase of 1.1976% from yesterday's close, completing a monthly increase of 2.1148% or NT$0.35. Over the past 12 months, 1451 stock lost -2.3121%.
1451 pays dividends to its shareholders, with the most recent payment made on May 18, 2026. The next estimated payment will be in In 11 months on May 18, 2027 for a total of NT$1.
The last earnings report, released on May 07, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Nien Hsing Textile Co., Ltd. has completed 7 stock splits, with the recent split occurring on Sep 29, 2017.
The company's stock is traded on one exchange.

1451 Chart

People also search for

Nak Sealing Technologies Corp.
NT$ 118.5
-0.4202%
Federal Corporation
NT$ 18.15
-0.8197%
YC Co., Ltd.
NT$ 16.15
+0.3106%
Sampo Corporation
NT$ 23.35
-0.2137%
Power Wind Health Industry Co. Ltd.
NT$ 145
-0.3436%

Nien Hsing Textile Co., Ltd. (1451) FAQ

What is the stock price today?

The current price is NT$16.90.

On which exchange is it traded?

Nien Hsing Textile Co., Ltd. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 1451.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 4%.

What is its market cap?

As of today, the market cap is 3.43B.

Has Nien Hsing Textile Co., Ltd. ever had a stock split?

Nien Hsing Textile Co., Ltd. had 7 splits and the recent split was on Sep 29, 2017.

Nien Hsing Textile Co., Ltd. Profile

Textiles, Apparel & Luxury Goods Industry
Consumer Discretionary Sector
Shu-Hsuan Tsai CEO
TWSE Exchange
TW0001451003 ISIN
TW Country
- Employees
16 Apr 2026 Last Dividend
29 Sep 2017 Last Split
- IPO Date

Overview

Maxigen Biotech Inc. is a dynamic entity in the biomedical sector, focusing on the research, development, production, and sales of implantable medical devices and cosmetic products. With its operations spanning across Taiwan, America, Europe, Asia, and other international markets, the company has carved a niche for itself in two primary segments: Biomedical Products and Consumer Products. Since its inception in 1998, Maxigen Biotech Inc. has established its headquarters in Taoyuan City, Taiwan, marking its presence as a key player in the global market.

Products and Services

Maxigen Biotech Inc. offers a diverse portfolio of products and services designed to meet the needs of patients and consumers worldwide. These include:

  • ArtiAid, ArtiAid Plus, and ArtiBest: A series of intra-articular injections aimed at treating osteoarthritis, offering patients relief from joint pain and improving mobility.
  • Foramic: This bone substitute granule serves as an alternative to traditional bone graft materials, aiding in the healing process of bone defects and injuries.
  • FormaGraft: Another innovative bone graft substitute designed to promote bone regeneration and repair in various orthopedic and dental applications.
  • GingivAid: These collagen dental grafts are used in dental implant surgery to enhance the success rate of implants by promoting better gum healing and integration.
  • BestAid: A collagen-based bone graft product specifically engineered to support bone regeneration and healing in both dental and orthopedic procedures.
  • FormaAid: This guided tissue regeneration membrane is utilized to facilitate the growth of new tissue, optimizing recovery in various medical procedures.
  • HealiAid: A collagen wound dressing tailored for dental and surgical applications, promoting faster and more efficient healing of wounds.
  • PreviscAid, BiVisc, and ViscAid: A range of ophthalmic viscoelastic devices and systems designed to protect and stabilize the eye during surgery, ensuring safer and more effective procedures.
  • Formaderm: Dermal filler injections offered under the Formaderm brand, aimed at aesthetic enhancements and anti-aging treatments.

In addition to its focus on biomedical products, Maxigen Biotech Inc. also engages in the manufacturing and sales of beauty care products, further expanding its reach in the consumer market.

Contact Information

Address: No 306, Neihu Road, Taipei, Taiwan, 114663
Phone: 886 2 2656 8888